Cudetaxestat

· Blade Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cudetaxestat, covering 2022-05-18 to 2022-05-18. Get the full timeline:

Most recent: Clinical Trial Update: RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]